Osimertinib Frontline for EGFR Mutated Resistance Mechanisms Not Fully Understood - 102262

Spotlight
Video

Osimertinib Frontline for EGFR Mutated Resistance Mechanisms Not Fully Understood

Loading........
Description: Anne S. Tsao, MD of MD Anderson Cancer Center discusses Osimertinib in frontline for EGFR mutated resistance mechanisms and how they are not fully understood from the 22nd Annual Perspectives in Thoracic Oncology in New York http://imedex.com/perspecti...
Shared By : thoraciconcology
Posted on : 12/29/17
Added : 22 days ago



Recommended

Nothing found.

More From thoraciconcology

Nothing found.